| scholarly article | Q13442814 |
| P2093 | author name string | J A King | |
| B Lu | |||
| V Csizmadia | |||
| W Gao | |||
| W W Hancock | |||
| S T Smiley | |||
| C J Gerard | |||
| P S Topham | |||
| P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| Molecular characterization of two murine eosinophil beta chemokine receptors | Q28292130 | ||
| Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor | Q28297700 | ||
| Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
| Chronic rejection and its risk factors | Q33541436 | ||
| Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity | Q36598908 | ||
| Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury | Q37373611 | ||
| Induction of members of the IL-8/NAP-1 gene family in human T lymphocytes is suppressed by cyclosporin A | Q39632930 | ||
| Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytes: effect of cyclosporin A. | Q41158427 | ||
| Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth. | Q41486400 | ||
| Orbital fibroblast chemokine modulation: effects of dexamethasone and cyclosporin A. | Q41955296 | ||
| Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages | Q42460197 | ||
| Specificity and reciprocity in the interactions between TGF-beta and macrophage inflammatory protein-1 alpha. | Q47634467 | ||
| Dual origin of intimal cells in cardiac-allograft arteriosclerosis | Q47742141 | ||
| Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages | Q50335914 | ||
| Function of cryopreserved arterial allografts under immunosuppressive protection with cyclosporine A. | Q50992514 | ||
| Suppression of allograft responses induced by interleukin-6, which selectively modulates interferon-gamma but not interleukin-2 production. | Q54488226 | ||
| Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways | Q56908985 | ||
| Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site | Q56943333 | ||
| Macrophage inflammatory protein 1 modulates macrophage function | Q68107144 | ||
| Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro | Q71217167 | ||
| Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching | Q71520447 | ||
| Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy | Q72601430 | ||
| Gene expression of macrophage inflammatory protein-1 alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4 | Q72850382 | ||
| Immunosuppressive drugs inhibit the production of interleukin-6 and interleukin-8 in cultured cardiac myxoma cells | Q74327779 | ||
| Adoptively transferable tolerance induced by CD45RB monoclonal antibody | Q77361906 | ||
| Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection | Q77394206 | ||
| Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes | Q77658697 | ||
| Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque | Q77682519 | ||
| Chemokine receptor (CXCR4) mRNA-expressing leukocytes are increased in human renal allograft rejection | Q77736877 | ||
| Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts | Q77848927 | ||
| Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates | Q77890140 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiology | Q10379 |
| P304 | page(s) | 35-44 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection | |
| P478 | volume | 105 |
| Q83335555 | A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation |
| Q34934535 | A model for reactivation of CMV from latency |
| Q40845773 | A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection |
| Q33841123 | Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency |
| Q35648369 | Allograft arteriopathy: pathogenesis update |
| Q73267376 | Allograft rejection in a new allospecific CD4+ TCR transgenic mouse |
| Q36643353 | Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours |
| Q40271425 | Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD. |
| Q73072584 | Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection |
| Q34189273 | Broad-spectrum chemokine inhibition ameliorates experimental obliterative bronchiolitis. |
| Q57570908 | CC chemokine receptor 5 and renal-transplant survival |
| Q34378583 | CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial disease |
| Q36196440 | CCR1 antagonists in clinical development |
| Q40812380 | CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model |
| Q36384883 | CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation |
| Q63968503 | CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model |
| Q42605598 | CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases |
| Q36410601 | Cardiac allograft vasculopathy: the Achilles' heel of long-term survival after cardiac transplantation |
| Q36333439 | Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies |
| Q24800857 | Chemokine blockade: a new era in the treatment of rheumatoid arthritis? |
| Q35829676 | Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation |
| Q34754683 | Chemokine receptor antagonism as an approach to anti-inflammatory therapy: 'just right' or plain wrong? |
| Q37481238 | Chemokine receptor antagonists: Part 1. |
| Q46270784 | Chemokine receptor polymorphism in transplantation immunology: no longer just important in AIDS. |
| Q74481121 | Chemokine receptors |
| Q34575325 | Chemokine receptors: multifaceted therapeutic targets |
| Q35583497 | Chemokine receptor‐dependent alloresponses |
| Q26741199 | Chemokines and Chemokine Receptors in the Development of Lupus Nephritis |
| Q28200068 | Chemokines and disease |
| Q35538137 | Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression |
| Q34046797 | Chemokines and their receptors in allograft rejection |
| Q36560836 | Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction |
| Q37256207 | Chemokines and transplant vasculopathy |
| Q34139602 | Chemokines as regulators of T cell differentiation. |
| Q41899798 | Chemokines in innate and adaptive granuloma formation |
| Q34241116 | Chemokines, chemokine receptors, and allograft rejection |
| Q34786928 | Chemokines: directing leukocyte infiltration into allografts |
| Q34139595 | Chemokines: immunology's high impact factors |
| Q38430487 | Comparative Transcriptomic Analysis of Porcine Peripheral Blood Reveals Differentially Expressed Genes from the Cytokine-cytokine Receptor Interaction Pathway Related to Health Status |
| Q35190604 | Coronary artery vasculopathy in pediatric cardiac transplant patients: the therapeutic potential of immunomodulators |
| Q44592649 | Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression |
| Q36363303 | Cytomegalovirus CC chemokine promotes immune cell migration |
| Q43416695 | Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles |
| Q42972486 | Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection |
| Q41765008 | Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival |
| Q35119358 | Development and evaluation of pharmacological agents targeting chemokine receptors |
| Q45868935 | Differential Chemokine and Chemokine Receptor Gene Induction by Ischemia, Alloantigen, and Gene Transfer in Cardiac Grafts |
| Q40584252 | Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways |
| Q44601106 | Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by Statins |
| Q36369253 | Donor-derived IP-10 initiates development of acute allograft rejection |
| Q39758876 | Expression of CXCR6 on CD8(+) T cells was up-regulated in allograft rejection |
| Q43828382 | FTY720: a new dimension in transplantation |
| Q34129761 | Gene targeting of chemokines and their receptors |
| Q45856772 | Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival |
| Q24793685 | HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection |
| Q38619142 | Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function. |
| Q44437789 | Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease |
| Q73308674 | IL-10 synergistically enhances GM-CSF-induced CCR1 expression in myelomonocytic cells |
| Q28375207 | Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1 |
| Q54668273 | Immunomonitoring of renal transplant recipients in the early posttransplant period by sequential analysis of chemokine and chemokine receptor gene expression in peripheral blood mononuclear cells. |
| Q43655794 | Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection |
| Q40731683 | Increased levels of CD4(+) and CD8(+) T cells expressing CCR1 in patients developing allograft dysfunction; a cohort study. |
| Q28752308 | Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection |
| Q42025217 | Innate immunity and resistance to tolerogenesis in allotransplantation |
| Q24625668 | Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2 |
| Q35048826 | Knock out models to dissect chemokine receptor function in vivo |
| Q40736768 | Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4. |
| Q26998846 | Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders? |
| Q38050766 | Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation |
| Q57202180 | Modulation of Innate Immune Cells to Create Transplant Tolerance |
| Q36370261 | Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival |
| Q28576109 | Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection |
| Q35583526 | Optimal modes and targets of gene therapy in transplantation |
| Q41603563 | Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo |
| Q36351689 | Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists |
| Q40655205 | Proinflammatory cytokines induce NF-κB-Dependent/NO-independent chemokine gene expression in MIN6 β cells |
| Q24676298 | Requirement of the chemokine receptor CXCR3 for acute allograft rejection |
| Q34206393 | Routes to allograft survival |
| Q78423840 | Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy |
| Q40707327 | Shikonin, a component of antiinflammatory Chinese herbal medicine, selectively blocks chemokine binding to CC chemokine receptor-1. |
| Q52866764 | Spiegelmer Inhibition of MCP-1/CCR2--Potential as an Adjunct Immunosuppressive Therapy in Transplantation. |
| Q35095437 | Stem cell origins of intimal cells in graft arterial disease |
| Q28349698 | Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection |
| Q24337078 | The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization |
| Q38834435 | The chemokines CCR1 and CCRL2 have a role in colorectal cancer liver metastasis |
| Q35031907 | The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury |
| Q34083104 | The role of the graft endothelium in transplant rejection: evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection |
| Q46927946 | Unaltered levels of transplant arteriosclerosis in the absence of the B cell homing chemokine receptor CXCR5. |
| Q38336371 | Unique gene expression profiles of heart allograft rejection in the interferon regulatory factor-1-deficient mouse |
| Q95840792 | Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells |
Search more.